Job Opportunities API

The Public Ledger of Openings

← Back to the ledger

Associate Director, SEC Reporting & Technical Accounting

Vaxcyte
CompanyVaxcyte
CategoryFinance
LocationSan Carlos
RemoteOn-site (inferred)
EmploymentNot stated
LevelDirector
SalaryNot stated by the employer
Posted26 Feb 2026
Last verified7 Aug 2026
SourceEmployer ATS (greenhouse)
Applications are handled by the employer, not by us.Apply on the employer's site →
Description
Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance.    WHAT  we do is every bit as important as  HOW  we do it! Our work together is guided by four enduring core values:   *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered.   *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind.   *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives.   *MODEL EXCELLENCE:  The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: The Associate Director, SEC Reporting & Technical Accounting will serve as a key contributor to the company’s external reporting and technical accounting function. Reporting to the Senior Director, Technical Accounting & SEC Reporting, this role will be highly hands-on, owning the preparation and execution of SEC filings and technical accounting analyses while also managing one direct report.  This role is ideal for a technically strong accounting professional who enjoys operating in the details, partnering cross-functionally, and helping build processes in a growing public biotechnology company.  Essential Functions: SEC Reporting (Hands-On Execution)  Own the preparation of quarterly and annual SEC filings, including Forms 10-Q, 10-K, and 8-K  Prepare and/or review primary financial statements, footnotes, and related disclosures in accordance with U.S. GAAP and SEC requirements  Draft and support MD&A disclosures, with emphasis on R&D, G&A, stock-based compensation, and other pre-revenue biotech-specific areas  Coordinate the quarterly close-to-reporting process across Accounting, FP&A, Legal, and external auditors  Support earnings release tie-outs and disclosure controls  Technical Accounting  Support technical accounting assessments and documentation for complex transactions, including:  Collaboration, licensing, and R&D-related arrangements  Equity and equity-linked financing transactions  Other complex and other non-routine transactions  Research new accounting standards and SEC guidance; assess applicability and implementation impact  Draft clear, well-supported technical accounting memos and communicate conclusions to stakeholders  Strong experience in ASC 842, including the identification, classification, and accounting of lease arrangements, as well as the preparation and review of related disclosures in compliance with U.S. GAAP People Management  Manage and mentor one direct report, providing coaching, review, and development support  Review work products to ensure accuracy, quality, and adherence to timelines  Foster strong execution discipline and continuous improvement within the reporting function  Process Improvement & Scaling  Help design and enhance scalable SEC reporting and technical accounting processes as the company grows  Partner with cross-functional teams to ensure accounting and reporting considerations are incorporated